BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• KEMRI and NEC Announce Trials on Biometric-based Vaccination Management System for Newborn Children in Kenya

  The Kenya Medical Research Institute, NEC Corporation and Nagasaki University have developed a digital biometric-based vaccination management system for newborn children in Kenya.

  February 6, 2023

   · 

  2 min read
• J INTS BIO, Oral TKI ‘JIN-A04', poster presentation of HER2 exon20 insertion mutation in NSCLC

  J INTS BIO announced that the preclinical results of “JIN-A04,” a novel oral tyrosine kinase inhibitor targeting HER2 Exon20 insertion mutation in NSCLC, will be presented at the upcoming 2023 American Cancer Research Association meeting in Orlando, U.S. from April 14 to 19.

  February 6, 2023

   · 

  1 min read
• Drug Development

  Phase II Study of Orelabrutinib in Patients with R/R CLL/SLL Published by American Journal of Hematology

  American Journal of Hematology recently published the phase 2 study result of BTK inhibitor orelabrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma patients.

  February 6, 2023

   · 

  4 min read
• Drug Development

  Carina Biotech to Present Preclinical Data at Lorne Cancer 2023 Supporting Effectiveness of LGR5-Targeted CAR-T Cell Therapy Platform in Ovarian Cancer Tumor Models

  Carina Biotech Pty Ltd (Carina), a cell therapy immuno-oncology company, today announced that a poster presentation with preclinical data supporting the effectiveness of its LGR5-targeted CAR-T platform in ovarian cancer cell models will be presented at the 35th Annual Lorne Cancer Conference.

  February 6, 2023

   · 

  2 min read
• Alvotech Enters Into Commercialization Agreement With Advanz Pharma for Proposed Biosimilar to Xolair® (Omalizumab)

  Alvotech announced that it has entered into an exclusive agreement with Advanz Pharma, for the commercialization of AVT23, a proposed biosimilar to Xolair®.

  February 6, 2023

   · 

  7 min read
• Policy

  Inmagene receives IND clearance for IMG-008, a long-acting IL-36R mAb

  Inmagene Biopharmaceuticals announced that the U.S. Food and Drug Administration recently granted the initial investigational new drug application for its drug candidate IMG-008, a long-acting anti-IL-36R antibody with enhanced half-life and exposure.

  February 6, 2023

   · 

  3 min read
• Biotech Beach

  Element to Present Data and Innovation Roadmap at AGBT

  Element Biosciences, Inc. will present details about its new Avidity Cloudbreak™ technology and the company’s innovation roadmap at the Advances in Genome Biology and Technology General Meeting Feb. 6-9, 2023, in Hollywood, FL.

  February 6, 2023

   · 

  3 min read
• BioForest

  NanoString Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology (AGBT)

  NanoString Technologies, Inc. today announced an update to the technology roadmap for the CosMx™ Spatial Molecular Imager (SMI) that will be presented at the 2023 Advances in Genome Biology and Technology General Meeting in Hollywood, FL.

  February 6, 2023

   · 

  4 min read
• Biotech Bay

  Slingshot Biosciences Announces $11 Million in Series A3 Financing

  Slingshot Biosciences today announced the closing of $11 million in a Series A3 financing.

  February 6, 2023

   · 

  3 min read
• Biotech Bay

  NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Discuss DERMAdoctor’s Eczema Treatment on Two QVC® Shows on February 7

  NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Discuss DERMAdoctor’s Eczema Treatment on Two QVC ® Shows on February 7.

  February 6, 2023

   · 

  5 min read